Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors

Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors

We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant...

Full description

Bibliographic Details
Main Authors: Simona Murko, Manuela Peschka, Konstantinos Tsiakas, Sebastian Schulz-Jürgensen, Uta Herden, René Santer
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Glycogen storage disease Ib
GSD1b
Liver transplantation
SGLT2 inhibitor
Empagliflozin
Online Access:http://www.sciencedirect.com/science/article/pii/S221442692300023X

Internet

http://www.sciencedirect.com/science/article/pii/S221442692300023X

Similar Items